Table 10.

Serum adipokine levels in patients with ALD according to the presence of the disease complications.

	Ascites						P
	Absent (n = 58)			Present (n = 89)
	Median	95% CI	25–75 P	Median	95% CI	25–75 P
Acrp30 µg/mL	16.94	14.78–23.04	10.16–29.62	23.33	17.93–37.81	14.55–74.20	0.013
Leptin ng/mL	10.47	8.42–11.89	6.34–15.13	6.80	4.40–9.88	2.20–13.32	0.054
Resistin ng/mL	17.15	11.62–24.88	9.33–32.27	16.75	15.13–18.54	11.36–28.08	0.70
	Hepatic encephalopathy						P
	Absent (n = 127)			Present (n = 20)
	Median	95% CI	25–75 P	Median	95% CI	25–75 P
Acrp30 µg/mL	17.93	16.08–23.38	11.76–41.82	55.65	23.11–164.21	22.62–164.55	0.003
Leptin ng/mL	8.82	6.80–10.49	2.75–14.27	6.42	3.06–12.63	2.76–13.33	0.54
Resistin ng/mL	16.37	14.39–18.91	10.30–29.69	18.17	16.03–20.86	15.83–21.36	0.55
	Oesophageal varices						P
	Absent (n = 60)			Present (n = 87)
	Median	95% CI	25–75 P	Median	95% CI	25–75 P
Acrp30 µg/mL	17.55	15.20–23.11	11.76–31.42	23.61	17.91–33.14	14.68–51.66	0.16
Leptin ng/mL	8.88	3.66–11.88	2.00–13.94	8.38	5.97–10.13	3.23–13.56	0.69
Resistin ng/mL	18.73	14.40–22.34	9.09–27.24	15.83	13.46–17.53	11.14–28.31	0.59
	Cholestasis						P
	Absent (n = 117)			Present (n = 30)
	Median	95% CI	25–75 P	Median	95% CI	25–75 P
Acrp30 µg/mL	18.22	16.33–29.60	10.60–68.81	20.10	14.13–25.37	11.76–41.45	0.77
Leptin ng/mL	8.94	7.03–10.69	3.84–15.14	5.23	2.27–10.92	2.00–11.90	0.07
Resistin ng/mL	15.29	13.37–16.99	9.28–26.81	19.74	17.11–31.21	13.46–33.87	0.02
	Renal dysfunction						P
	Creatinine < 1.3 mg/dL (n = 125)			Creatinine ≥ 1.3 mg/dL (n = 22)
	Median	95% CI	25–75 P	Median	95% CI	25–75 P
Acrp30 µg/mL	18.22	16.65–24.07	11.50–44.27	22.63	17.03–46.19	16.33–161.19	0.12
Leptin ng/mL	9.23	6.80–10.91	3.11–15.00	7.56	2.00–9.08	2.00–10.09	0.18
Resistin ng/mL	16.18	13.46–17.87	10.23–26.08	29.22	16.98–39.77	16.75–63.53	0.001